Extrafine beclometasone/LABD formulations did not increase pneumonia risk versus LABD
| dc.contributor.author | Singh, Dave | |
| dc.contributor.author | Price, David | |
| dc.contributor.author | Henley, William | |
| dc.contributor.author | Delfini Cançado, José Eduardo | |
| dc.contributor.author | Fabbri, Leonardo M | |
| dc.contributor.author | Kerstjens, Huib AM | |
| dc.contributor.author | Papi, Alberto | |
| dc.contributor.author | Roche, Nicolas | |
| dc.contributor.author | Şen, Elif | |
| dc.contributor.author | Vogelmeier, Claus F | |
| dc.contributor.author | Nudo, Elena | |
| dc.contributor.author | Carter, Victoria | |
| dc.contributor.author | Skinner, Derek | |
| dc.contributor.author | Vella, Rebecca | |
| dc.contributor.author | Soriano, Joan B | |
| dc.contributor.author | Kots, Maxim | |
| dc.contributor.author | Georges, George | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2025-01-03T00:07:07Z | |
| dc.date.available | 2025-01-03T00:07:07Z | |
| dc.date.embargoedUntil | 2025-01-03 | |
| dc.date.issued | 2024-03-26 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 154342 | |
| dc.identifier | 283494933 | |
| dc.identifier | d0f13a85-a7e8-4ba8-b63d-85498d2c2812 | |
| dc.identifier.citation | Singh, D, Price, D, Henley, W, Delfini Cançado, J E, Fabbri, L M, Kerstjens, H AM, Papi, A, Roche, N, Şen, E, Vogelmeier, C F, Nudo, E, Carter, V, Skinner, D, Vella, R, Soriano, J B, Kots, M & Georges, G 2024, 'Extrafine beclometasone/LABD formulations did not increase pneumonia risk versus LABD', TSANZSRS 2024, Gold Coast, Australia, 23/03/24 - 26/03/24. | en |
| dc.identifier.citation | conference | en |
| dc.identifier.uri | https://hdl.handle.net/2164/24819 | |
| dc.language.iso | eng | |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Extrafine beclometasone/LABD formulations did not increase pneumonia risk versus LABD | en |
| dc.type | Conference item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Singh_etal_Extrafine_beclometasone_LABD_AAM.pdf
- Size:
- 150.72 KB
- Format:
- Adobe Portable Document Format
